Clinical TrialsSearch results
Number of results: 701
Other
- Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607)
- clinical T1 gastric cancer without submucosal invasion
- Japan Clinical Oncology Group (JCOG)
- 2007-06-08
Recruiting
- Phase II trial of docetaxel/pembrolizumab in head and neck squamous cell carcinoma
- head and neck squamous cell carcinoma
- Shimizu Yasushi
- 2022-02-01
Other
- Phase II trial of combination chemotherapy consisting of S-1 and Oxaliplatin in patients with advanced or recurrent mucinous adenocarcinoma of the ovary
- Mucinous adenocarcinoma of the ovary including metastatic ovarian cancer
- Japan ovarian mucinous adenocarcinoma study group
- 2009-01-01
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28
Other
- Phase II trail of docetaxel and ramucirumab combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer (HGCSG1903)
- Gastric cancer
- Komatsu Yoshito
- 2020-11-18
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancer
- inoperable locally advanced stage IIIA/IIIB non-small cell lung cancer
- National Hospital Study Group for Lung Cancer
- 2009-08-26
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Phase II study of S-1 in patients with gemcitabine-refractory advanced biliary tract cancer
- Patients with gemcitabine-refractory advanced biliary tract cancer
- National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division
- 2007-12-01
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28